Literature DB >> 21223543

Cognitive and autonomic dysfunction measures in normal controls, white coat and borderline hypertension.

Abdullah Shehab1, Abdishakur Abdulle.   

Abstract

BACKGROUND: White coat hypertension (WCHT) is a significant clinical condition with haemodynamic differences and presence of functional changes. We aim to compare cognitive and autonomic dysfunction variables (heart rate variability) between subjects with normal blood pressure (controls), WCHT, and borderline hypertension (BLH).
METHODS: We performed a cross-sectional study in a cohort of 69 subjects (mean age ± SD; 38.2 ±10.8 years) comprising comparable number of normal controls, WCHT, and BLH. We measured clinic and 24-hour ambulatory blood pressure monitoring (ABPM), cognitive function parameters, and heart rate variability (HRV). All subjects underwent 24-hour ambulatory electrocardiography monitoring which was analyzed for HRV measurements. We performed a routine echocardiography (ECHO) for all subjects.
RESULTS: Multiple comparison between the three groups revealed significant (p < 0.04) differences in mean day-time ABPM (systolic and diastolic). In the state anxiety inventory (SAI), both subjects with WCHT and BLH had significantly (p < 0.006) higher anxiety levels than the control group. In memory tasks WCHT subjects scored significantly (p < 0.004) lower in comparison with the other two groups. WCHT significantly (p < 0.001) performed less in memory tests, whereas BLH subjects had significantly (p < 0.001) lower reaction time. We found a significant (p < 0.05) difference in the 24-hour RMSSD and SDNN between the three groups. There was significant correlation between 24-hour RMSSD and computer CANTAB scores. The Echocardiography assessment revealed no significant differences in LV mass indices and diastolic function.
CONCLUSIONS: WCHT and BLH subjects showed lower cognitive performance and higher levels of anxiety when compared to controls. Autonomic function reflected by HRV indices was lower in WCHT and BLH in contrast to control, though not significantly. Our results suggest that WCHT may not be a benign condition as it may contribute to the overall risk for cardiovascular disease and LV damage. Longitudinal studies of patients with WCHT should clarify the transient, persistent or the progressive nature of this condition.

Entities:  

Mesh:

Year:  2011        PMID: 21223543      PMCID: PMC3023785          DOI: 10.1186/1471-2261-11-3

Source DB:  PubMed          Journal:  BMC Cardiovasc Disord        ISSN: 1471-2261            Impact factor:   2.298


  34 in total

1.  Masked hypertension.

Authors:  Thomas G Pickering; Karina Davidson; William Gerin; Joseph E Schwartz
Journal:  Hypertension       Date:  2002-12       Impact factor: 10.190

2.  White-coat effect in normotension and hypertension.

Authors:  Nikos A Zakopoulos; Vasilios T Kotsis; Vassiliki Ch Pitiriga; Savvas T Toumanidis; John P Lekakis; Serafim N Nanas; Kostas N Vemmos; Stamatios F Stamatelopoulos; Spyridon D Moulopoulos
Journal:  Blood Press Monit       Date:  2002-10       Impact factor: 1.444

Review 3.  Relationships among heart rate variability, hypertension, and relaxation techniques.

Authors:  Sangthong Terathongkum; Rita H Pickler
Journal:  J Vasc Nurs       Date:  2004-09

Review 4.  Ambulatory blood pressure monitoring in primary care.

Authors:  Randy Wexler
Journal:  South Med J       Date:  2010-05       Impact factor: 0.954

5.  Reliability of echocardiographic assessment of left ventricular structure and function: the PRESERVE study. Prospective Randomized Study Evaluating Regression of Ventricular Enlargement.

Authors:  V Palmieri; B Dahlöf; V DeQuattro; N Sharpe; J N Bella; G de Simone; M Paranicas; D Fishman; R B Devereux
Journal:  J Am Coll Cardiol       Date:  1999-11-01       Impact factor: 24.094

6.  Alterations of cardiac structure in patients with isolated office, ambulatory, or home hypertension: Data from the general population (Pressione Arteriose Monitorate E Loro Associazioni [PAMELA] Study).

Authors:  R Sega; G Trocino; A Lanzarotti; S Carugo; G Cesana; R Schiavina; F Valagussa; M Bombelli; C Giannattasio; A Zanchetti; G Mancia
Journal:  Circulation       Date:  2001-09-18       Impact factor: 29.690

7.  Gender differences in the relation of hypertension to cognitive function in older adults.

Authors:  Shari R Waldstein; Leslie I Katzel
Journal:  Neurol Res       Date:  2004-07       Impact factor: 2.448

Review 8.  Task Force II: blood pressure measurement and cardiovascular outcome.

Authors:  J A Staessen; R Asmar; M De Buyzere; Y Imai; G Parati; K Shimada; G Stergiou; J Redón; P Verdecchia
Journal:  Blood Press Monit       Date:  2001-12       Impact factor: 1.444

9.  British Hypertension Society guidelines for hypertension management 2004 (BHS-IV): summary.

Authors:  Bryan Williams; Neil R Poulter; Morris J Brown; Mark Davis; Gordon T McInnes; John F Potter; Peter S Sever; Simon McG Thom
Journal:  BMJ       Date:  2004-03-13

10.  Effects of immediate versus delayed antihypertensive therapy on outcome in the Systolic Hypertension in Europe Trial.

Authors:  Jan A Staessen; Lutgarde Thijisq; Robert Fagard; Hilde Celis; Willem H Birkenhäger; Christopher J Bulpitt; Peter W de Leeuw; Astrid E Fletcher; François Forette; Gastone Leonetti; Patricia McCormack; Choudomir Nachev; Eoin O'Brien; José L Rodicio; Joseph Rosenfeld; Cinzia Sarti; Jaakko Tuomilehto; John Webster; Yair Yodfat; Alberto Zanchetti
Journal:  J Hypertens       Date:  2004-04       Impact factor: 4.844

View more
  9 in total

1.  Acute psychological stress, autonomic function, and arterial stiffness among women.

Authors:  Jeongok G Logan; Bethany A Teachman; Xiaoyue Liu; Charles R Farber; Zhenqi Liu; Brian H Annex
Journal:  Int J Psychophysiol       Date:  2020-06-30       Impact factor: 2.997

2.  Impact of HIV on Cognitive Performance in Professional Drivers.

Authors:  Hetta Gouse; Catherine J Masson; Michelle Henry; Anna Dreyer; Reuben N Robbins; Greg Kew; John A Joska; Leslie London; Thomas D Marcotte; Kevin G F Thomas
Journal:  J Acquir Immune Defic Syndr       Date:  2022-04-15       Impact factor: 3.771

3.  Racial differences in the association between heart rate variability and left ventricular mass.

Authors:  LaBarron K Hill; Lana L Watkins; Alan L Hinderliter; James A Blumenthal; Andrew Sherwood
Journal:  Exp Physiol       Date:  2017-05-26       Impact factor: 2.969

Review 4.  Neurocognitive alterations in hypertensive children and adolescents.

Authors:  Marc B Lande; Juan C Kupferman; Heather R Adams
Journal:  J Clin Hypertens (Greenwich)       Date:  2012-05-21       Impact factor: 3.738

5.  Non-alcoholic fatty liver disease may develop in individuals with normal body mass index.

Authors:  Ekaterini Margariti; Melanie Deutsch; Spilios Manolakopoulos; George V Papatheodoridis
Journal:  Ann Gastroenterol       Date:  2012

6.  The Development of Explicit and Implicit Game-Based Digital Behavioral Markers for the Assessment of Social Anxiety.

Authors:  Martin Johannes Dechant; Julian Frommel; Regan Lee Mandryk
Journal:  Front Psychol       Date:  2021-12-15

Review 7.  Pathogenetic Mechanisms of Hypertension-Brain-Induced Complications: Focus on Molecular Mediators.

Authors:  Tiziana Di Chiara; Alessandro Del Cuore; Mario Daidone; Stefania Scaglione; Rosario Luca Norrito; Maria Grazia Puleo; Rosario Scaglione; Antonio Pinto; Antonino Tuttolomondo
Journal:  Int J Mol Sci       Date:  2022-02-23       Impact factor: 5.923

8.  Heart rate variability and target organ damage in hypertensive patients.

Authors:  Paolo Melillo; Raffaele Izzo; Nicola De Luca; Leandro Pecchia
Journal:  BMC Cardiovasc Disord       Date:  2012-11-15       Impact factor: 2.298

Review 9.  Hypertension, brain damage and cognitive decline.

Authors:  Dariusz Gąsecki; Mariusz Kwarciany; Walenty Nyka; Krzysztof Narkiewicz
Journal:  Curr Hypertens Rep       Date:  2013-12       Impact factor: 5.369

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.